APOE and Alzheimer disease: Interestingly, if both genotype and vitamin D levels were considered in the same study, it has been found that, among late-onset AD patients, 25(OH)D3 insufficiency was observed only in ApoE-ɛ 4 non-carriers, thus suggesting the use of vitamin D as a possible disease biomarker only in this category of patients [346,362].